- $10.04bn
- $7.22bn
- $4.15bn
- 88
- 57
- 73
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,134 | 1,762 | 2,842 | 3,826 | 4,154 |
Cost of Revenue | |||||
Gross Profit | 609 | 916 | 1,391 | 1,814 | 2,044 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,504 | 2,255 | 3,757 | 5,032 | 5,077 |
Operating Profit | -370 | -493 | -916 | -1,205 | -923 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -362 | -504 | -961 | -1,244 | -997 |
Provision for Income Taxes | |||||
Net Income After Taxes | -307 | -491 | -950 | -1,256 | -1,015 |
Net Income Before Extraordinary Items | |||||
Net Income | -307 | -491 | -950 | -1,256 | -1,015 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -307 | -491 | -950 | -1,256 | -1,015 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.28 | -3.17 | -5.31 | -6.2 | -3.46 |